Mammogen
PrivateLast Round
Series A
Jun 3, 2026
Total Funding Raised
$33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mammogen is a biotechnology company that develops RNA-powered molecular diagnostic devices designed to improve the detection, diagnosis, and treatment of women's health-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mammogen Comparables
Compare Mammogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrin Biosciences | 90% | |
| Syantra Inc. | 85% | |
| OncoTAb | 81% | |
Mammogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 3, 2026 | ||||
| Seed | Jun 30, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 6247% MoM, from 15 to 952.
- Jun 3, 2026
$30M round completed.
Mammogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mammogen's valuation, stock price, and market status.